FDANews
FDAnews Device Daily Bulletin

Devicemaker Avinger Investigated For Potential Misconduct Surrounding IPO

July 17, 2017

Devicemaker Avinger is the subject of a corporate misconduct investigation by shareholder rights attorneys Haeggquist & Eck.

The investigation involves alleged false and misleading statements executives made in connection with Avinger’s January 2015 initial public offering.

The company is already the target of several securities class action suits after projecting its 2016 revenue as significantly lower than a previous estimate.

View today's stories